Paulette A. Lyle - Concepedia

Author

Paulette A. Lyle

Merck & Co., Inc., Rahway, NJ, USA (United States)

Also Known As

P A Lyle, P Lyle, P. A. LYLE, P. A. Lyle, P.A. Lyle, Paulette A Lyle, Paulette A. Lyle, Paulette Lyle

Publications

1.7K

Citations

H-Index

Concepts

All Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)United States Military Academy Sahlgrenska University Hospital Cornell University Oslo University Hospital

About

Paulette A. Lyle is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in medicine, pharmacology, and cardiovascular disease.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	13	17	905
2	Natural Sciences	5	5	293
3	Public Health	5	5	451
4	Engineering	2	2	96
5	Social Sciences	1	1	68

Paulette A. Lyle

Publications

1.5K

Citations

H-Index

Page 1

	Year	Citations
Risk Scores for Predicting Outcomes in Patients with Type 2 Diabetes and Nephropathy William F. Keane, Zhongxin Zhang, Paulette A. Lyle, Clinical Journal of the American Society of Nephrology HypertensionRenal FunctionDiabetes EpidemiologyClinical EpidemiologyPublic Health	2006	193
Thienothiopyran-2-sulfonamides: a novel class of water-soluble carbonic anhydrase inhibitors G. S. PONTICELLO, Mark B. Freedman, Charles N. Habecker, Journal of Medicinal Chemistry Inhibitory ActivityMedicinal ChemistryPharmaceutical ScienceBioorganic ChemistryCarbonic Anhydrase Activity	1987	110
Hospitalizations for New Heart Failure Among Subjects With Diabetes Mellitus in the RENAAL and LIFE Studies Albert A. Carr, Peter R. Kowey, Richard B. Devereux, The American Journal of Cardiology Heart FailureHealth PolicyCardiovascular DiseaseLife StudiesDiabetes	2005	108
Does Albuminuria Predict Cardiovascular Outcomes on Treatment With Losartan Versus Atenolol in Patients With Diabetes, Hypertension, and Left Ventricular Hypertrophy? Hans Ibsen, Michael Hecht Olsen, Kristian Wachtell, Diabetes Care	2006	105
Cyclization-activated prodrugs. Basic carbamates of 4-hydroxyanisole Walfred S. Saari, J. E. SCHWERING, Paulette A. Lyle, Journal of Medicinal Chemistry Medicinal ChemistryPharmaceutical ScienceBioorganic ChemistryBiochemistryNatural Sciences	1990	101
ACE Gene Polymorphism and Losartan Treatment in Type 2 Diabetic Patients With Nephropathy Hans‐Henrik Parving, Dick de Zeeuw, Mark E. Cooper, Journal of the American Society of Nephrology HypertensionGenetic EpidemiologyGlomerulonephritisRenal FunctionPublic Health	2008	90
An efficient synthesis of arylpyrazines and bipyridines Wayne J. Thompson, James H. Jones, Paulette A. Lyle, The Journal of Organic Chemistry Molecular SciencesEngineeringDonut IconAltmetric Attention ScoreChemometrics	1988	79
Synthesis and pharmacological evaluation of a series of dibenzo[a,d]cycloalkenimines as N-methyl-D-aspartate antagonists Wayne J. Thompson, Paul Anderson, Susan F. Britcher, Journal of Medicinal Chemistry Combinatorial ChemistryRat Cortical SlicePharmacotherapyChemistryAntagonist Activity	1990	68
The effect of losartan on hemoglobin concentration and renal outcome in diabetic nephropathy of type 2 diabetes Anupama Mohanram, Zhong-yan Zhang, S. Shahinfar, Kidney International	2007	68
Effects of Losartan in Women With Hypertension and Left Ventricular Hypertrophy Ingrid Os, Verónica Franco, Sverre E. Kjeldsen, Hypertension	2008	66

Page 1